Filter by Category

How to Prove Liability for AI Hallucinations in Healthcare: Negligence, Product Liability, or Malpractice?

Proving liability for an AI “hallucination” in healthcare typically requires 3 core showings: a duty of care, a verifiable false output, and a causal link to patient harm. As hospitals and clinicians deploy generative AI for triage, documentation, imaging support, and patient messaging, the same tool can create confident but incorrect medical content. This article explains how plaintiffs and defense counsel analyze negligence, product liability, and malpractice theories, and what evidence most often decides the case.

What counts as an “AI hallucination” in healthcare litigation?

In litigation, an “AI hallucination” is not a clinical mystery—it is a provably false AI-generated statement presented with apparent authority. In healthcare settings, hallucinations commonly appear as: (1) invented citations or guidelines in clinical decision support; (2) fabricated symptoms, histories, or exam findings inserted into documentation; (3) erroneous medication doses or contraindication advice; (4) misstatements about imaging findings; or (5) incorrect patient instructions delivered through portals or chatbots.

The key legal move is to translate “hallucination” into conventional evidentiary terms: a false representation, a defect, a breach of a standard of care, or an unreasonable risk that was foreseeable and preventable. Once framed that way, liability analysis looks like any other healthcare injury case—duty, breach, causation, damages—layered with product and information-system issues.

The three primary liability pathways: negligence, malpractice, and product liability

AI hallucination cases typically present overlapping theories. Plaintiffs often plead multiple counts because the facts can support more than one duty bearer: the treating clinician, the facility that deployed the tool, and the vendor that designed and marketed it.

1) Professional malpractice (clinician-focused)

Malpractice centers on whether a licensed professional met the applicable standard of care in using (or relying on) AI output. Even when the AI is “only advisory,” a plaintiff may argue the clinician’s reliance was unreasonable given the patient’s presentation, the known limitations of the tool, or contradictory clinical data.

2) Institutional or operational negligence (hospital/health system-focused)

Negligence claims against a hospital or clinic often target selection, configuration, implementation, training, credentialing, supervision, and monitoring of AI tools. These cases resemble EHR and patient safety system litigation: the facility’s duty is to deploy technology safely, not merely to purchase it.

3) Product liability (vendor-focused)

Product theories typically allege defective design, manufacturing (rare for software but sometimes framed as release/patch errors), and failure to warn/instruct. For software, plaintiffs often focus on foreseeable misuse (overreliance), inadequate guardrails, inadequate validation, and misleading marketing claims about accuracy, safety, or clinical performance.

Malpractice: proving breach when a clinician relied on a hallucination

To establish malpractice, a plaintiff must typically show: (1) a provider-patient relationship creating a duty; (2) breach of the professional standard of care; (3) causation; and (4) damages. The AI component affects breach and causation most.

How plaintiffs argue breach

Common breach theories include:

Failure to independently evaluate AI output. If the AI generated a diagnosis, dosing recommendation, or risk score that a reasonable clinician would verify against vitals, labs, imaging, allergies, or guidelines, uncritical acceptance can be framed as substandard.

Ignoring “red flags” that the output was unreliable. Examples: the AI cited non-existent studies; it contradicted patient-specific contraindications; it provided an unusually high dose; it used outdated guideline language; or it produced internally inconsistent statements.

Improper delegation of clinical judgment. Plaintiffs may argue the clinician treated the AI as the decision-maker rather than a tool, especially where documentation suggests “per AI” reasoning without clinical synthesis.

Documentation malpractice tied to hallucinations. If a generative tool fabricated exam findings or histories and the clinician signed the note, plaintiffs can argue the record is inaccurate, undermining care continuity and evidencing lack of appropriate assessment.

How defense counsel counters breach

Defense arguments often focus on reasonableness under time, information, and workflow constraints, as well as widespread practice. Defendants may show the clinician used AI as one input among many, cross-checked key facts, followed institutional protocol, and made an independent clinical judgment. Another defense theme: the hallucination was not readily detectable, and the provider acted consistently with peer practice at the time.

Expert testimony: what the standard of care looks like with AI

In many jurisdictions, standard-of-care proof requires qualified expert testimony. Expect experts to opine on what a reasonably prudent clinician should do when presented with AI-generated recommendations: verify critical contraindications, confirm source credibility, document rationale, and avoid using the tool outside its intended use. Defense experts may emphasize that AI output is probabilistic and that clinicians are not guarantors of perfect outcomes.

Negligence against hospitals: implementation, governance, and monitoring failures

Institutional liability often turns on technology governance. Plaintiffs may claim a facility breached its duty by deploying AI without appropriate evaluation, guardrails, training, or oversight. These cases frequently target system-level failures rather than individual clinical decisions.

Common negligence theories against facilities

Negligent selection and procurement. Choosing a tool without adequate validation for the intended patient population or use case (e.g., using a general-purpose chatbot for clinical guidance).

Negligent implementation and configuration. Poor prompt templates, risky default settings, or EHR integrations that auto-populate notes without requiring review.

Inadequate training and policies. No clear policy on permitted uses, verification steps, prohibited uses (e.g., dosing), or escalation procedures when AI output appears wrong.

Failure to monitor performance and incidents. Not tracking hallucination rates, adverse events, near misses, bias or drift, and not updating or disabling the tool when problems emerge.

Unsafe workflow design. Deploying AI in high-velocity environments (ED triage, nurse messaging queues) without sufficient staffing or review checkpoints can make errors foreseeable.

Key evidence in institutional AI negligence cases

Discovery often focuses on governance artifacts: vendor evaluations, pilot results, internal risk assessments, committee minutes, training materials, user logs, override rates, incident reports, and post-deployment monitoring dashboards. Plaintiffs also seek communications about known hallucination problems and what the organization did (or did not do) after learning of them.

Product liability: design defect and failure-to-warn theories for AI “products”

When the defendant is a developer or vendor, plaintiffs may pursue product liability—especially if the AI was marketed for clinical use or embedded in a clinical system. The legal viability depends on state law and how courts treat software and AI-enabled services, but the recurring theories are familiar: defective design and inadequate warnings.

Design defect (software/AI)

A design defect theory may assert the product’s architecture made hallucinations unreasonably likely or unreasonably dangerous for the intended use. Plaintiffs may argue feasible alternative designs existed, such as:

Hard constraints preventing certain outputs (e.g., dosing recommendations) unless validated against patient-specific data.

Retrieval safeguards requiring cited sources to be drawn from a vetted knowledge base, not free-form generation.

Confidence and uncertainty signaling that meaningfully alerts users when the model is guessing.

Human-in-the-loop controls that force review before outputs are entered into the medical record or sent to patients.

Failure to warn / inadequate instructions

Failure-to-warn claims often center on whether the vendor adequately disclosed hallucination risk, contraindicated uses, accuracy limits, known failure modes, and necessary verification steps. Marketing and sales materials become critical: if a vendor represented the tool as “accurate,” “clinically validated,” or “reducing errors,” plaintiffs will argue those claims increased foreseeable reliance and raised the duty to warn.

Regulatory status and the FDA angle

Some healthcare AI may be regulated as Software as a Medical Device (SaMD) or as clinical decision support, depending on functionality and claims. FDA clearance/authorization (or lack thereof) can matter in several ways: it may support defense arguments about reasonable design and warnings, or it may support plaintiffs’ arguments about unauthorized intended use or misleading promotion. Even where federal law does not create a private right of action, regulatory facts can shape negligence and failure-to-warn narratives.

Causation: the hardest element in hallucination cases

Even with a clear false output, liability usually hinges on causation: did the hallucination actually cause the injury, and was it a foreseeable result of the breach or defect?

Proving “but-for” causation and proximate cause

Plaintiffs typically must show the injury would not have occurred absent reliance on the hallucinated information. This often requires a timeline anchored to objective records: when the output was generated, who saw it, what action it prompted, and what would have been done otherwise. Proximate cause focuses on foreseeability: was it foreseeable that clinicians or staff would rely on a plausible-sounding output in that workflow?

Intervening acts and shared fault

Defendants often argue intervening clinical judgment breaks the causal chain: a clinician chose to act, so the AI did not “cause” the harm. Plaintiffs counter with foreseeability—if the product and deployment encouraged reliance, clinician action may be a foreseeable link rather than a superseding cause. Comparative fault issues arise where multiple actors contributed (e.g., nurse used AI message template; physician signed; hospital set auto-insert; vendor failed to warn).

Loss of chance and delayed diagnosis frameworks

In delayed diagnosis scenarios, hallucinations might steer triage away from urgent workup (e.g., dismissing red flags, inventing a benign explanation). Some jurisdictions recognize loss-of-chance theories, which can be pivotal when the patient’s underlying condition was already life-threatening but earlier intervention would have improved the outcome.